Engineered beta-cyclodextrin-based carrier for targeted doxorubicin delivery in breast cancer therapy in vivo

Title
Engineered beta-cyclodextrin-based carrier for targeted doxorubicin delivery in breast cancer therapy in vivo
Authors
Keywords
Beta-cyclodextrin (β-CD), Polyethylene glycol (PEG), Folic acid (FA), Doxorubicin (DOX), Breast cancer therapy
Journal
JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY
Volume 70, Issue -, Pages 145-151
Publisher
Elsevier BV
Online
2018-10-27
DOI
10.1016/j.jiec.2018.09.052

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started